Source comparison
Dosing Protocols: Maintenance vs Acute Administration
Two dosing paradigms exist in melanotan-2 sexual health research: chronic low-dose maintenance (100–250mcg daily or every other day) and acute high-dose event administration (1–1.5mg 2–6 hours pre-activity). Maintenance protocols sustain baseline receptor occu
This comparison does not assign a generated winner or score.
- Two dosing paradigms exist in melanotan-2 sexual health research: chronic low-dose maintenance (100–250mcg daily or every other day) and acute high-dose event administration (1–1.5mg 2–6 hours pre-activity). Maintenance protocols sustain baseline receptor occupancy, increasing spontaneous libido and reducing refractory period between sexual events. Acute protocols maximize peak-window arousal but require precise timing and produce stronger side effects (nausea, facial flushing, transient hypertension).
- Maintenance dosing structure: 100–250mcg administered subcutaneously once daily or every 48 hours. This range produces measurable increases in spontaneous sexual thoughts, morning erections, and partner-initiated desire without requiring scheduled activity. The trade-off is slower onset (effects emerge over 5–10 days as receptor density upregulates) and less pronounced peak arousal compared to acute dosing. Clinical data from a 2009 study in International Journal of Impotence Research found that men on 250mcg daily maintenance reported 40% increases in sexual frequency over 12 weeks, driven primarily by increased initiation rather than improved erectile quality.
- Acute event dosing structure: 0.5–1.5mg administered 2–4 hours before planned sexual activity. Onset begins at 90–120 minutes (subjective arousal, increased genital sensitivity), peaks at 3–5 hours (maximal erectile response, reduced refractory period), and fades by 10–12 hours. First-time users should start at 0.5mg to assess nausea tolerance. GI side effects are dose-dependent and peak at the same 2–4 hour window as sexual effects. Pre-dosing with 25mg diphenhydramine or 10mg domperidone reduces nausea incidence from 60% to under 20% without blunting MC4R activation.
- Our experience with research teams using both paradigms: acute dosing produces more dramatic subjective reports ('strongest arousal I've experienced', 'inability to lose erection even post-orgasm') but requires planning and side effect management. Maintenance dosing integrates into daily routines without event-planning but yields subtler improvements that some users interpret as placebo until they discontinue and notice the contrast.